Today: 10 June 2026
Tesla stock dips as Musk kills the $8,000 Full Self-Driving buy option
14 January 2026
1 min read

Tesla stock dips as Musk kills the $8,000 Full Self-Driving buy option

New York, January 14, 2026, 10:11 EST — Regular session

Tesla shares dropped roughly 1.8% Wednesday morning following CEO Elon Musk’s announcement that the company will phase out one-time purchases of its Full Self-Driving software, switching to a subscription-only model. The stock slipped $7.98 to $439.22, after closing Tuesday at $447.20.

The timing is tricky for a stock driven as much by its software ambitions as its vehicles. Investors are focused on whether Tesla can steady its revenue from driver-assistance—and if regulators will allow it to do so.

The math shifts for customers too. While a subscription might boost adoption, it can just as easily frustrate those who preferred a one-and-done payment.

Musk announced on X that Tesla will “stop selling FSD after Feb 14” and that going forward, “FSD will only be available as a monthly subscription.” Right now, Tesla offers FSD (Supervised) in the U.S. for $8,000 upfront or $99 monthly, according to Investing.com. Investing.com South Africa

Tesla has consistently emphasized that the feature isn’t fully autonomous. In a previous statement about its subscription rollout, the company clarified that the current capabilities “do not make the vehicle autonomous” and “require a fully attentive driver, who has their hands on the wheel.” Reuters

Safety concerns continue to weigh on sentiment. In October, the U.S. National Highway Traffic Safety Administration launched an investigation into 2.88 million Tesla vehicles fitted with Full Self-Driving after reports surfaced of traffic violations and crashes. The agency warned it could mandate a recall if it determines there’s an unreasonable risk. Oliver Carsten, a transport safety professor at the University of Leeds, described the probe as “a wake-up call for Europe.” Reuters

In a separate regulatory filing, Tesla awarded Senior Vice President Xiaotong Zhu a non-qualified stock option for 520,021 shares, priced at $435.80 each. The grant date for this award was Jan. 8. The Form 4 filing detailed a vesting schedule spanning multiple years.

Tesla is also dealing with legal pressure. The company has agreed to mediation with the U.S. Equal Employment Opportunity Commission over a racism lawsuit linked to its Fremont, California, factory. According to a court filing, talks could begin in March or April.

That said, shifting to subscriptions isn’t a guaranteed win. If users resist the monthly charges, the “take rate”—or the percentage of owners paying for the software—might barely budge. On top of that, another safety hiccup could put even more pressure on the strategy.

Tesla will release its fourth-quarter earnings Wednesday, Jan. 28, after markets close. The company also plans a live Q&A webcast at 5:30 p.m. Eastern, it said.

Stock Market Today

  • Kalshi Co-Founder Predicts Prediction Markets Will Surpass Stock Exchanges
    June 10, 2026, 5:42 PM EDT. Kalshi co-founder and COO Luana Lopes Lara stated at Web Summit Rio on June 10, 2026, that prediction markets could become larger than traditional stock exchanges despite potential losses for participants. Prediction markets involve trading contracts based on event outcomes, differing from equity markets by focusing on future predictions rather than ownership. Lopes Lara highlighted Kalshi's readiness to collaborate closely with regulatory bodies to ensure compliance and foster growth. This outlook underscores the growing interest in alternative trading platforms challenging conventional financial markets.

Latest articles

Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Freshworks Stock Steady at $9.39 Ahead of AI Test

Freshworks Stock Steady at $9.39 Ahead of AI Test

10 June 2026
Freshworks traded flat near $9.39 on volume more than double average as investors weighed its AI-driven restructuring and Freshservice focus; with Q2 restructuring costs looming, the stock faces a key test to prove AI shifts can boost margins without hurting growth, while net dollar retention dipped to 106% and large-customer ARR rose 29%.
Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod
Previous Story

Nvidia stock braces for a China shock as customs blocks H200 AI chips despite U.S. export nod

Shopify’s AI shopping push puts checkout inside Google Gemini and Microsoft Copilot
Next Story

Shopify’s AI shopping push puts checkout inside Google Gemini and Microsoft Copilot

Go toTop